Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat vs Darbepoetin Alfa in Non-Dialysis CKD Anemia Conversion Study
NCT02988973Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roxadustat in anemia of chronic kidney disease (CKD-A), sponsored by Astellas Pharma. Started Jan 2017; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02988973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02988973.